# NEUTREXIN
> **NDA020326** · New Drug Application · Sponsor: MEDIMMUNE ONCOLOGY · Approved 1993-12-17
## Drug
- **FDA Application Number:** NDA020326
- **Application type:** New Drug Application
- **Brand name:** NEUTREXIN
- **Generic name:** Trimetrexate Glucuronate
- **Active ingredients:** TRIMETREXATE GLUCURONATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** MEDIMMUNE ONCOLOGY
- **First approval:** 1993-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020326)
---
*MORVS · CC0 1.0*